Concepedia

Hoda Sharifian

HS

Statistics

Publications

1

Citations

51

H-Index

1

Active since

2024

Affiliations

AstraZeneca (United Kingdom)(Current)

Hoda Sharifian is an author at AstraZeneca (United Kingdom).

ORCID

Publications per year

2024–2024

1

Publications

1

Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials

Tina Baker, Hoda Sharifian, Paul J. Newcombe et al. · Annals of the Rheumatic Diseases · 2024 · 51 citations · Full text

1–1 of 1